Background: Silicone oil (SO) is used as an intravitreal tamponade agent in vitreoretinal surgery for rhegmatogenous retinal detachment (RRD) complicated by proliferative vitreoretinopathy or with large, multiple retinal tears. Usually, SO is left in the eye for at least 3 months. Although its use can lead to well-known complications, intraocular SO is generally well tolerated. Some studies have reported unexpected central vision loss after SO use or removal. Objective: To investigate and analyze the reason for visual loss after the use or removal of intraocular SO in patients who underwent vitrectomy surgeries for RRD. Patients and Methods: A retrospective observational case series of 12 patients with macula-on RRD who reported visual loss after the use or removal of SO was reviewed. Investigations carried out included fundus fluorescein angiography, optical coherence tomography (OCT) of the macula and optic disc, perimetry, and electrophysiological study. Electrolyte levels were measured in retro-oil fluid and compared with their levels in the vitreous humor of patients who underwent vitrectomy for macular holes, floaters, dropped intraocular lenses, or dropped crystalline lens fragments. Results: Visual acuity levels dropped by at least 2 Snellen chart lines. None of the 12 cases had macular detachment at any stage. Fundus fluorescein angiography and OCT results were unremarkable in most of the cases. Mean levels of electrolytes in retro-oil fluids and vitreous humor were similar. Conclusion: Visual loss is a possible complication after SO use or removal. This still remains a mysterious issue which needs further research and investigation.

1.
Azen SP, Scott IU, Flynn HW Jr, et al: Silicone oil in the repair of complex retinal detachments. A prospective observational multicenter study. Ophthalmology 1998;105:1587-1597.
2.
Camacho H, Bajaire B, Mejia LF: Silicone oil in the management of giant retinal tears. Ann Ophthalmol 1992;24:45-49.
3.
Alexandridis E: Silicone oil tamponade in the management of severe hemorrhagic detachment of the choroids and ciliary body after surgical trauma. Ophthalmologica 1990;200:189-193.
4.
Yeo JH, Glaser BM, Michels RG: Silicone oil in the treatment of complicated retinal detachments. Ophthalmology 1987;94:1109-1113.
5.
Lesnoni G, Rossi T, Nistri A, et al: Long-term prognosis after removal of silicone oil. Eur J Ophthalmol 2000;10:60-65.
6.
Newsom RS, Johnston R, Sullivan PM, et al: Sudden visual loss after removal of silicone oil. Retina 2004;24:871-877.
7.
Herbert EN, Laidlaw DA, Williamson TH, et al: Loss of vision once silicone oil has been removed. Retina 2005;25:808-809; author reply 809.
8.
Cazabon S, Groenewald C, Pearce IA, et al: Visual loss following removal of intraocular silicone oil. Br J Ophthalmol 2005;89:799-802.
9.
Satchi K, Bolton A, Patel CK: Loss of vision once silicone oil has been removed. Retina 2005;25:807-808; author reply 808.
10.
Moya R, Chandra A, Banerjee PJ, et al: The incidence of unexplained visual loss following removal of silicone oil. Eye (Lond) 2015;29:1477-1482.
11.
Herbert EN, Habib M, Steel D, et al: Central scotoma associated with intraocular silicone oil tamponade develops before oil removal. Graefes Arch Clin Exp Ophthalmol 2006;244:248-252.
12.
Winter M, Eberhardt W, Scholz C, et al: Failure of potassium siphoning by Müller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci 2000;41:256-261.
13.
Azzolini C, Docchio F, Brancato R, et al: Interactions between light and vitreous fluid substitutes. Arch Ophthalmol 1992;110:1468-1471.
14.
Dogramaci M, Williams K, Lee E, et al: Foveal light exposure is increased at the time of removal of silicone oil with the potential for phototoxicity. Graefes Arch Clin Exp Ophthalmol 2013;251:35-39.
15.
Asaria RH, Kon CH, Bunce C, et al: Silicone oil concentrates fibrogenic growth factors in the retro-oil fluid. Br J Ophthalmol 2004;88:1439-1442.
16.
Shalchi Z, Mahroo OA, Shunmugam M, et al: Spectral domain optical coherence tomography findings in long-term silicone oil-related visual loss. Retina 2015;35:555-563.
17.
Tode J, Purtskhvanidze K, Oppermann T, et al: Vision loss under silicone oil tamponade. Graefes Arch Clin Exp Ophthalmol 2016;254:1465-1471.
18.
Williams PD, Fuller CG, Scott IU, et al: Vision loss associated with the use and removal of intraocular silicone oil. Clin Ophthalmol 2008;2:955-959.
19.
Scheerlinck LM, Kuiper JJ, Liem AT, et al: Electrolyte composition of retro-oil fluid and silicone oil-related visual loss. Acta Ophthalmol 2016;94:449-453.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.